Interviews

Patricia Carney, OBGYN, director of medical affairs, head of women’s health, Organon, shares the prevalence and impact of maternal health deserts in the United States, as well as advice for enhancing access and reducing racial disparities in...

In this interview, Brian Sistani, PharmD, discusses preliminary findings from his research into how disruptions caused by COVID-19 impacted statin adherence.

Brett Furst, president, HHS Technology Group, provides insight into the COVID-19 Research Database, including how researchers and policymakers are using the database to understand long COVID-19, social determinants of health, and more. 

“Even a small improvement on engagement translates into huge impacts on outcomes and satisfaction, which also means cost savings for the whole industry,” says Jason Burum, general manager, Provider Segment, Clinical Effectiveness, Wolters...

John Fryer, president, Tribus, and senior vice president of national markets, Lumeris, offers insight into challenges providers have come up against when switching from fee-for-service to value-based payment models and shares how accelerated...

Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.

Morris Panner, JD, president, Intelerad, discusses the mammography and lung cancer diagnostics markets, as well as the effect of technology expansions on care from both patient and payer perspectives.

Mark Braunstein, MD, professor of the practice emeritus at Georgia Tech and board of directors’ member at Rimdi, Inc, discusses current interoperability policies and what they mean for providers and payers.